Péter Farkas Selected Research

Péter Farkas Research Topics

4	Thrombotic Thrombocytopenic Purpura 01/2019 - 04/2014
3	Thrombotic Microangiopathies 01/2019 - 01/2017
2	Multiple Myeloma 11/2019 - 01/2018
2	acquired Thrombotic thrombocytopenic purpura 01/2018 - 02/2017
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 02/2017
1	Disease Progression 01/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020
1	Hemolytic-Uremic Syndrome 01/2019
1	Essential Thrombocythemia 01/2018
1	Primary Myelofibrosis (Myelosclerosis) 01/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2017
1	Neoplasms (Cancer) 01/2017
1	Sepsis (Septicemia) 01/2017
1	Acute Disease 04/2014
1	Breast Neoplasms (Breast Cancer) 03/2008
1	Neoplasm Metastasis (Metastasis) 03/2008

5	thiamine triphosphorate (TTP)IBA 01/2019 - 04/2014
2	ibrutinibIBA 01/2021 - 01/2020
2	AutoantibodiesIBA 01/2018 - 02/2017
2	ADAMTS13 ProteinIBA 01/2018 - 01/2016
2	Leukocyte Elastase (Neutrophil Elastase)IBA 05/2016 - 04/2014
1	Phospholipase C gammaIBA 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	Monoclonal AntibodiesIBA 11/2019
1	daratumumabIBA 11/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	N 30IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Thalidomide (Thalomid)FDA Link 10/2017
1	Protein Tyrosine PhosphatasesIBA 02/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2017
1	Peptide Hydrolases (Proteases)FDA Link 02/2017
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	von Willebrand FactorIBA 01/2016
1	Edetic Acid (EDTA)FDA Link 04/2014
1	Diphosphonates (Bisphosphonates)IBA 03/2008

2	Therapeutics 01/2018 - 10/2017
1	Extracorporeal Circulation 01/2017
1	Organ Transplantation 01/2017
1	Aftercare (After-Treatment) 01/2017